STAT

At 83, AIDS activist Larry Kramer isn’t done ripping into his foes in pharma, FDA, and NIH

AIDS activist Larry Kramer has become synonymous with savage attacks on public officials and drug companies. At 83, he has not mellowed one bit.

Over the course of three decades, the name Larry Kramer has become synonymous with the gay rights movement, patient rights — and savage attacks on public officials and drug companies.

Today, with controversy over drug prices and concern over public health funding, we were curious what Kramer had on his mind. We also wondered whether at the age of 83 he has mellowed.

He has not.

“I don’t mince any words,’’ he said.

His take on Francis Collins, director of the National Institutes of Health: “Collins is a wimp.’’

On Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases: “The consummate manipulative bureaucrat who speaks out of too many sides of his mouth.’’

On Gilead,: “Gilead is evil, pure and simple.’’

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks